Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Almirall ( (ES:ALM) ).
Almirall, S.A. has announced the upcoming Ordinary General Shareholders’ Meeting scheduled for May 9, 2025, to discuss and approve various fiscal matters for the year 2024, including annual accounts, dividend distribution, and director re-elections. The meeting will also address a proposed increase in share capital and other governance-related issues, reflecting the company’s strategic focus on financial growth and corporate governance enhancement.
More about Almirall
Almirall, S.A. is a pharmaceutical company that operates in the healthcare industry, focusing on the development and commercialization of innovative medicines, primarily in the field of dermatology. The company aims to address unmet medical needs and improve patient outcomes through its specialized products and services.
YTD Price Performance: 24.63%
Average Trading Volume: 3,097
Technical Sentiment Signal: Sell
Current Market Cap: €2.15B
See more insights into ALM stock on TipRanks’ Stock Analysis page.